«We've responded to the competitive environment by focusing on industries that are currently out of favor with the public - equity market,
like biotech, medical devices, and
early -
stage information -
technology companies,» says Patrick Boroian, a general partner at Sprout, which is the New York City - based venture - capital affiliate of financial - services giant Donaldson, Lufkin & Jenrette.